1. Home
  2. MMI vs PLSE Comparison

MMI vs PLSE Comparison

Compare MMI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMI
  • PLSE
  • Stock Information
  • Founded
  • MMI 1971
  • PLSE 2014
  • Country
  • MMI United States
  • PLSE United States
  • Employees
  • MMI N/A
  • PLSE N/A
  • Industry
  • MMI Real Estate
  • PLSE Medical/Dental Instruments
  • Sector
  • MMI Finance
  • PLSE Health Care
  • Exchange
  • MMI Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • MMI 1.5B
  • PLSE 1.3B
  • IPO Year
  • MMI 2013
  • PLSE 2016
  • Fundamental
  • Price
  • MMI $37.50
  • PLSE $19.47
  • Analyst Decision
  • MMI Sell
  • PLSE
  • Analyst Count
  • MMI 1
  • PLSE 0
  • Target Price
  • MMI $30.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • MMI 102.8K
  • PLSE 164.0K
  • Earning Date
  • MMI 02-14-2025
  • PLSE 03-27-2025
  • Dividend Yield
  • MMI 1.32%
  • PLSE N/A
  • EPS Growth
  • MMI N/A
  • PLSE N/A
  • EPS
  • MMI N/A
  • PLSE N/A
  • Revenue
  • MMI $696,060,000.00
  • PLSE N/A
  • Revenue This Year
  • MMI $19.64
  • PLSE N/A
  • Revenue Next Year
  • MMI $22.25
  • PLSE N/A
  • P/E Ratio
  • MMI N/A
  • PLSE N/A
  • Revenue Growth
  • MMI 7.76
  • PLSE N/A
  • 52 Week Low
  • MMI $29.93
  • PLSE $6.60
  • 52 Week High
  • MMI $42.80
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • MMI 48.38
  • PLSE 45.49
  • Support Level
  • MMI $37.27
  • PLSE $20.59
  • Resistance Level
  • MMI $39.25
  • PLSE $22.23
  • Average True Range (ATR)
  • MMI 1.15
  • PLSE 1.70
  • MACD
  • MMI 0.10
  • PLSE -0.32
  • Stochastic Oscillator
  • MMI 23.45
  • PLSE 5.31

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: